We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BLDR:NYSEBuilders FirstSource, Inc. Analysis

Data as of 2026-05-20 - not real-time

$66.39

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Builders FirstSource (BLDR) is trading at $66.39, barely above its 30‑day support of $66.14 and well below its 20‑day SMA of $78.63, indicating a near‑term price ceiling. The stock’s RSI of 27.9 and a bearish MACD histogram suggest momentum is still weak, while a beta of 1.64 and 30‑day volatility above 50% point to heightened price swings. Fundamentally, the forward PE of 11.3 is markedly lower than the trailing PE of 25.3 and the industry average PE of 29.2, hinting at earnings acceleration. However, the DCF‑derived fair value of roughly $28.8 is less than half the current price, flagging a substantial valuation gap. Analyst consensus remains a “Buy” with a median target near $95, driven by expectations of a housing demand rebound and operational initiatives. Recent news highlights renewed market attention on housing demand and BLDR’s strategic positioning, yet short‑term performance lags the broader market, down 10% versus a +9.5% S&P 500 move. The company’s high debt‑to‑equity ratio and thin operating margin add pressure, while cash flow remains positive but modest. Overall, the stock sits at a technical crossroads with bearish signals, but a potential earnings upswing could narrow the valuation disconnect over the medium horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering at technical support
  • Bearish momentum indicators (RSI, MACD)
  • Elevated volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward earnings growth narrowing valuation gap
  • Analyst targets averaging $95
  • Potential rebound in housing demand

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant valuation disparity to DCF fair value
  • High leverage and thin operating margins
  • Cyclical nature of building products sector

Key Metrics & Analysis

Financial Health

Revenue Growth-10.10%
Profit Margin1.97%
P/E Ratio25.3
ROE6.96%
ROA3.40%
Debt/Equity132.16
P/B Ratio1.8
Op. Cash Flow$1.2B
Free Cash Flow$640.9M
Industry P/E29.2

Technical Analysis

TrendBearish
RSI27.9
Support$66.14
Resistance$91.90
MA 20$78.63
MA 50$82.57
MA 200$109.90
MACDBearish
VolumeStable
Fear & Greed Index89.18

Valuation

Fair Value$28.82
Target Price$97.38
Upside/Downside46.68%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.64
Volatility51.32%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.